KUALA LUMPUR, Medidata, a Dassault Systèmes brand and the provider of clinical trial solutions to the life sciences industry, has been recognised as a Leader in Everest Group's first-ever PEAK Matrix Assessment for Electronic Data Capture (EDC) in life sciences. The report, which evaluated 20 providers, highlighted Medidata Rave EDC for its seamless integration with wearables, sensors, and electronic health records (EHRs), along with its advanced capabilities in source data verification, artificial intelligence (AI)-driven query management, and adverse event handling. 'We are honoured to be recognised as a Leader in EDC by Everest Group. Rave EDC, the industry gold standard, has led electronic data capture for decades. 'Given the constantly evolving healthcare landscape, we continue to innovate to meet the growing demands for decentralised trials, empowering sponsors to use real-time data and AI to drive innovation and efficiency in the development of life-saving treatments,' said Medidata Chief Executive Officer, Anthony Costello in a statement. Rave EDC earned recognition for its intuitive, low-code design, enabling rapid implementation of protocol amendments, and simplifying the creation of electronic case report forms (eCRFs), while maintaining data quality and integrity for clinical trial sponsors. The Everest Group report emphasised Medidata's strong brand presence among large and mid-sized pharmaceutical companies and its extensive partnerships with contract research organisations and clinical trial technology providers. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. Source: BERNAMA News Agency